Markets

Markets Overview Market Context

Briefs Calendar

Research

News Search AI Market Assistant Charts & News Instrument directory Macro Politics Prediction Markets News Archive

LIVECAST Markets

☀◐Theme

Menu

Home LIVECAST Markets Market Context Briefs Calendar News Search AI Market Assistant Charts & News Instrument directory Macro Politics Prediction Markets News Archive Account

Home News ArchiveChemours Maintained at Neutral by UBS

Live News EQUITY FLASH L impact Oct 05, 2026, 08:09 PM UTC

Chemours Maintained at Neutral by UBS

UBS maintained its Neutral rating on Chemours.

SquawkNews Desk

Use this page

Share or save this market-moving headline as a permanent SquawkNews URL. The live feed continues at /news.

Open live news feed Browse news archive Browse news categories Search related coverage

Related tickers

CC

Related stories

House of Doge Agrees to Acquire McQueen Labs Tokenization Platform and Assets House of Doge announced an agreement to acquire McQueen Labs’ tokenization platform and credit assets. It also plans to investigate financing alternatives and seek stockholder appr M impact | EQUITY | Oct 24, 2026, 01:05 PM UTC Sherritt to Pause Moa Mining as Fuel Constraints Disrupt Operations Sherritt expects to pause mining at its Moa joint venture in Cuba and place the processing plant on standby within the next week for planned maintenance. Fuel delivery resumption t M impact | EQUITY | Oct 24, 2026, 01:05 PM UTC Parabilis Reports 72.2% ORR in Zolucatetide Study; FDA Aligns on Phase 3 Parabilis reported a 72.2% objective response rate (13/18) at doses of at least 450 mg in a 32-week Phase 1/2 analysis of zolucatetide in desmoid tumors. The company said the FDA a M impact | EQUITY | Oct 24, 2026, 12:47 PM UTC AU Small Finance Bank Q2 Profit Jumps 53% to ₹858 Crore The lender reported net profit of ₹858 crore for the quarter ended September 30, 2026, up from ₹561 crore a year earlier. It attributed the increase to improved interest income. M impact | EQUITY | Oct 24, 2026, 11:49 AM UTC Castrol India Q3 Profit Falls 49% Sequentially Castrol India reported a 7.3% quarter-on-quarter decline in revenue to ₹1,734.7 crore, from ₹1,871.5 crore, as higher raw material costs and adverse currency movements weighed on p M impact | EQUITY | Oct 24, 2026, 11:43 AM UTC Eli Lilly Reports Sofe-M Ovarian Cancer Data: 79% Response Rate Eli Lilly announced new clinical data for investigational drug sofetabart mipitecan at the ESMO 2026 Congress in Madrid. The headline reports a 100% disease-control rate. M impact | EQUITY | Oct 24, 2026, 11:39 AM UTC

SQUAWK/NEWS

Independent financial newsroom. Editorial expertise and proprietary AI. Paid LiveCast brings live headlines, chart context and priority audio to your trading day. Free research tools remain available.

LiveCast passes from $15 · Institutional API access.

Start LiveCast

News & Research

Open LiveCast
Session Briefs
Market Context
Macro
Politics
Prediction Markets
News Archive

Markets & Tools

Charts & News
Markets Overview
US Stocks
Market Movers
Economic Calendar
Policy Calendar
AI Market Assistant
News Search
Instrument Directory

Guides

Charts & News Guide
How LiveCast Works
What Is an Audio Squawk?
Why News Moves Markets
News for Traders
How to Trade the News

Plans & API

Plans & Pricing
Institutional API
RSS Feed

Company

About
Why SquawkNews
Newsroom
Editorial Standards
Corrections
Contact us

© 2026 SquawkNews

Privacy Policy Terms of Use

SquawkNews publishes market information and context. It does not provide investment advice or trade recommendations.